Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers
Rapid development of antisense therapies can enable on-demand responses to new viral pathogens and make personalized medicine for genetic diseases practical. Antisense phosphorodiamidate morpholino oligomers (PMOs) are promising candidates to fill such a role, but their challenging synthesis limits...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2021
|
Online Access: | https://hdl.handle.net/1721.1/131157 |